Latest Articles

This article takes a look at how cryo-electron microscopy is emerging as a critical tool in the structural analysis of tau filaments and how it is helping to advance tauopathy research.

After a three-year absence, the Society for Neuroscience’s (SfN) annual meeting returns to San Diego from November 12–16. With 10 conference tracks to choose from, getting your calendar in order beforehand is essential. To help you out, we’ve picked five events that should be near the top of your schedule.

From tweets to toots – the online community #SciTwitter is considering a move from Twitter to an alternative online platform. In this article, we explore how Twitter has supported science communication and outreach over recent years, the motivations for migration and ask: where are you heading, #SciTwitter?

Could the same technology that trains the immune system against pathogens also be used as a preventative for depression and anxiety?

Technology Networks recently had the pleasure of speaking with Dr. Sam Barichievy, director in cell engineering at the biopharmaceutical company AstraZeneca. In this conversation, Dr. Barichievy shares her perspectives on what equality, diversity and inclusion entails, and how fostering inclusive environments can enable us to do better science.

A Phase II clinical trial investigating the efficacy of LSD-assisted psychotherapy for the treatment of anxiety has reported positive results. However, mixed data from a second group in the trial somewhat complicates the picture, highlighting the complex challenges of psychedelic clinical trial design.

Dr. Jenna Macciochi is a lecturer in immunology at the University of Sussex, where her research centers on understanding the role that nutrition and lifestyle play in human immunity.

Recently, an expose article was published revealing a potential fabrication of data by prominent investigators of Alzheimer’s disease. In this op-ed piece, Michael Kinch explores the catastrophic impact of scientific fraud.

The Binomial test, sometimes referred to as the Binomial exact test, is a test used in sampling statistics to assess whether a proportion of a binary variable is equal to some hypothesized value.

One sign that the tide around psychedelic science is changing is the decision by the organizers of the recent Federation of European Neuroscience Societies (FENS) conference, the largest such neuroscience event in Europe, to carve out a slot for this burgeoning area of research. Here's a summary of what went down.